Animal Models Offer New Insights Into Energy Metabolism in Multiple Sclerosis
Researchers at United Arab Emirates University in Abu Dhabi have recently published in the journal BMC Neuroscience…
Articles by Patricia Silva, PhD
LMU Researchers Identify Biomarker BCMA to Measure MS Severity
In a recent study published in the journal Nature Communications, LMU clinicians have clarified the lifespan of antibody-producing…
Researchers Suggest Short Transition Period Between Natalizumab and Fingolimod Therapies to Control RRMS Disease Activity
An international team led by researchers at the University Hospital Basel in Switzerland revealed that a short period of…
MS Views and News Hosting Events for MS Community in July
MS Views and News (MSVN), a non-profit organization that works to improve education, advocacy and service to empower and enhance…
MediciNova Announces Update On Phase 2b Trial of MN-166 (Ibudilast) Involving 255 Progressive MS Patients
MediciNova, Inc., a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with…
Adamas Begins Phase 2 Multiple Sclerosis Study for Patients with Walking Impairment
Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapies for chronic disorders of the central nervous system, recently announced the…
Bone Loss, Osteopenia and Multiple Sclerosis Explored in New Scholarly Review
In a recent review published in the journal Seminars in Arthritis and Rheumatism, German researchers explored the complexity…
Review Suggests PEG-IFN Therapy for Relapsing-Remitting Multiple Sclerosis Significantly Reduces Relapse Rates
A study recently published in the journal PLoS One compared the use of a specific treatment based…
Researchers Determine Specific Genetic Associations With Multiple Sclerosis
In a recent meta-analysis published in the International Journal of Molecular Sciences, a team of researchers found evidence regarding the…
Specific MicroRNA Expression Changes According to the Multiple Sclerosis Disease Stage
Researchers at the Don C. Gnocchi Foundation and the University of Milano in Italy recently discovered that the…
Another Study Focused on Stem Cells and Autoimmune Diseases Shows Promise
Researchers at Monash University and the MIMR-PHI Institute of Medical Research in Australia recently proposed that specific human…
MS Health Care Excellence Awards Launched in UK
UK-based MS Trust has announced the launch of new awards designed to distinguish healthcare professionals that are committed to treating and changing…
Jack Osbourne and Teva Launch New Educational Multiple Sclerosis Website
Reality TV star Jack Osbourne has partnered with Teva Pharmaceutical Industries Ltd. to launch a new website as part…
Innate Lymphoid Cell Identified As Cause of Multiple Sclerosis Gender Differences
In a recent study published in The Journal of Immunology, researchers from a Northwestern Medicine lab discovered a…
MS Patient Lifespan, Comorbidities Studied in New Research
Researchers at the University of Manitoba in Canada recently conducted a study that explored the differences in lifespan and comorbidities…
Multiple Sclerosis Community Celebrates World MS Day
World MS Day is celebrated on May 27 as a day dedicated to those who suffer from multiple sclerosis (MS). In…
AUBAGIO Included in Prince Edward Island Pharmacare
Canadian province Prince Edward Island (PEI) has approved the inclusion of Aubagio (teriflunomide) 14 mg in the PEI…
Progressive MS Challenges to Be Dicussed at CMSC Meeting
The needs of patients who suffer from progressive multiple sclerosis (MS) will be addressed in a presentation hosted by Alan…
Researchers Identify Potential Cause of Multiple Sclerosis Movement, Balance Problems
Researchers in the Department of Immunology at St. Jude Children’s Research Hospital in Memphis were able to identify a faulty “brake”…
New Potential Therapeutic Strategy to Halt Disease Progression in Multiple Sclerosis Developed
A new study recently published in the journal Annals of Neurology revealed a potential new therapeutic strategy…
International Multiple Sclerosis Conference to Focus on Patients’ Experience
The 4th International MS Patient Summit, which will be held on May 22 in Rome, Italy, will explore feedback from patients who suffer…
Case Study Explores Hypnosis as Potential Treatment For Multiple Sclerosis Symptoms
Two Dragons Hypnotherapy recently announced the results of a one-year case study that assessed the effects of hypnotherapy on a patient…
New Genetic Variant as Predictor of Patients’ Response to MS Treatment
A team led by researchers at San Raffaele Scientific Institute in Italy and Brigham and Women’s Hospital in Boston, Massachusetts…
MSAA Organizes Make a Splash Fundraising Event for Memorial Day
The Multiple Sclerosis Association of America (MSAA) is organizing a national fundraising campaign just in time for summer. The Swim…
Yale and MIT Researchers Discover a Key Immune Difference in Multiple Sclerosis Patients
A new study recently published in the journal Science Translational Medicine revealed a key difference in immune…
Singer Releases Song About MS Recovery After Receiving Stem Cell Therapy
Singer Kristen King began to experience fatigue, muscle weakness and later paralysis in some parts of the body in 2013,…
Celiac Disease Found to Be Linked to Increased Risk of Multiple Sclerosis, Nerve Damage
A study recently published in the journal JAMA Neurology revealed that celiac disease is linked to a…
Major Progressive MS Trial Completes Enrollment For Experimental Therapy
While multiple sclerosis (MS) is considered a rare condition with major unmet medical needs, the treatments for…
Researchers Identify Drugs That Promote Remyelination in Mice
In a recent publication in Nature, titled “Drug-based modulation of endogenous stem cells promotes functional…
Oral Drugs May Reduce Preference for Injectable Drugs in Multiple Sclerosis Treatment
Frost & Sullivan recently published a report entitled “A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics…